Lung Cancer Update cover image

Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lung Cancer Update

00:00

Electinib or Lore Latinib?

I think for most patients whole brain radiotherapy is something that really can be put aside. I would say that seryt nib right now based on its toxicity profile would not be entered into the conversation in my mind. It's bergat nib electinib or lore latinib and more broadly though it's more are you a person who wants to start with a second generation inhibitor? And we can talk about differences there too.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app